- Home >
- Research and Innovation >
- Technology transfer >
- Institut Curie start-ups
Institut Curie start-ups
Digital health
Abivax
Abivax is a clinical-stage biopharmaceutical company leveraging its multiple drug development platforms to treat patients suffering from inflammatory diseases, viral infections and cancer.
Avatar Medical
AVATAR MEDICAL creates patient avatars to help surgeons prepare their operations. Its technology instantly generates interactive 3D representations of patients from standard medical images in an immersive virtual reality context.
Deltablot
Deltablot offers laboratories professional support and hosting for its eLabFTW software, an open-source electronic laboratory notebook.
Dosisoft
DOSIsoft develops advanced software solutions for radiation oncology and nuclear medicine, with strong expertise in dosimetry.
One Biosciences
One Biosciences harnesses the power of single-cell analysis to unlock a new wave of precision targets and drugs for a wide range of difficult-to-treat conditions.
Biotechnology and biopharmaceuticals
Cereus Biosciences
Cereus Biosciences draws on its strong expertise in bioinformatics and immunology to revolutionize cancer treatment by developing “ready-to-use” therapeutic vaccines accessible to all.
Emglev Therapeutics
Emglev Tx leverages its unique proprietary platform of next-generation synthetic antibodies for the discovery and development of novel immunotherapies to address unmet medical needs in oncology.
Egle Therapeutics
Egle Therapeutics develops first-in-class immunotherapies targeting suppressor T regulatory cells (Tregs) for oncology and autoimmune diseases.
Feroscan
Feroscan specializes in the development of first-class personalized cytotoxics with a unique and innovative mode of action. The company's pipeline focuses on incurable cancers, such as ovarian cancer and triple-negative breast cancer.
Meiogenix
Meiogenix develops breeding technologies to exploit the unexplored genetic diversity of organisms. Meiogenix broadens natural biodiversity and helps develop new products to meet the world's food and industrial challenges.
Mnemo Therapeutics
Mnemo Therapeutics uses epigenetics to create targeted immuno-oncology treatments accessible to a broad patient population. Its approach to difficult-to-treat tumors is based on its expertise in immuno-epigenetics, combined with the latest developments in T-cell engineering.
NanoMedsyn
NanoMedSyn focuses on the creation and development of innovative therapies using targeted vectors. The company's platform has potential applications in cancer, metabolic, inflammatory and autoimmune diseases.
PEP-Therapy
PEP-Therapy is a French clinical-stage biotechnology company developing peptides as targeted therapies in oncology.
Ribonexus
Ribonexus develops new therapies to overcome drug resistance in cancer cells.
Stimunity
Stimunity develops best-in-class drugs on the STING pathway to activate the innate immune system. Its drugs stimulate patients' immune systems to fight infectious pathogens or cancer.
Valerio Therapeutics
Valerio Therapeutics is a clinical-stage biotechnology company paving the way for the development of innovative DNA decoy-based therapies.
Contract Research Organizations (CROs)
Cytoo
CYTOO is a preclinical drug discovery company specializing in muscle and neuromuscular disorders. The company partners its versatile patient-derived muscle drug discovery engine with pharmaceutical and biotech companies, and develops its own drug candidates.
Xentech
Xentech is a contract research organization dedicated to cancer biomarkers and translational oncology research, offering preclinical services to evaluate the anticancer potential of drug candidates.
Scientific instruments
Alvéole
Alvéole specializes in devices for controlling the cellular microenvironment. The company provides research laboratories with tools to create more reliable and reproducible in vitro cell models.
Fluigent
Fluigent is an international company that develops, manufactures and supports the most advanced microfluidic systems. Fluigent has the expertise and knowledge to provide the most cost-effective and technically advanced solutions to fluid control needs.
Inorevia
Inorevia develops a new generation of instruments to automate and miniaturize molecular biology and sample preparation protocols. The company aims to accelerate innovation in the life sciences through the development of robust, highly innovative laboratory instruments.
Microbrain Biotech
MicroBrain Biotech develops decision-making solutions based on cellular neural circuits to reduce risk in the drug R&D process.